A detailed history of Baird Financial Group, Inc. transactions in Globus Medical Inc stock. As of the latest transaction made, Baird Financial Group, Inc. holds 3,043 shares of GMED stock, worth $257,224. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,043
Previous 3,246 6.25%
Holding current value
$257,224
Previous $222,000 2.25%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$67.08 - $73.92 $13,617 - $15,005
-203 Reduced 6.25%
3,043 $217,000
Q2 2024

Aug 13, 2024

BUY
$49.79 - $68.85 $161,618 - $223,487
3,246 New
3,246 $222,000
Q2 2023

Aug 11, 2023

SELL
$52.61 - $59.54 $2,051 - $2,322
-39 Reduced 1.03%
3,731 $222,000
Q1 2023

May 15, 2023

SELL
$51.83 - $79.63 $6,634 - $10,192
-128 Reduced 3.28%
3,770 $213,000

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $6.51B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.